Legal & General Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-30,432
| Closed | -$4.15M | – | 3510 |
|
|
2020
Q3 | $4.15M | Sell |
30,432
-2,049
| -6% | -$218K | ﹤0.01% | 1433 |
|
|
2020
Q2 | $3.14M | Buy |
32,481
+5,703
| +21% | +$476K | ﹤0.01% | 1527 |
|
|
2020
Q1 | $1.26M | Sell |
26,778
-1,948
| -7% | -$125K | ﹤0.01% | 1777 |
|
|
2019
Q4 | $2.09M | Buy |
28,726
+5,273
| +22% | +$320K | ﹤0.01% | 1778 |
|
|
2019
Q3 | $1.22M | Buy |
23,453
+2,200
| +10% | +$117K | ﹤0.01% | 1911 |
|
|
2019
Q2 | $1.07M | Buy |
21,253
+7,497
| +54% | +$365K | ﹤0.01% | 1937 |
|
|
2019
Q1 | $715K | Buy |
13,756
+141
| +1% | +$6.5K | ﹤0.01% | 2069 |
|
|
2018
Q4 | $665K | Buy |
13,615
+775
| +6% | +$42.7K | ﹤0.01% | 2037 |
|
|
2018
Q3 | $837K | Buy |
12,840
+7,879
| +159% | +$463K | ﹤0.01% | 2003 |
|
|
2018
Q2 | $247K | Buy |
4,961
+1,312
| +36% | +$63.5K | ﹤0.01% | 2260 |
|
|
2018
Q1 | $178K | Sell |
3,649
-1,233
| -25% | -$64.1K | ﹤0.01% | 2326 |
|
|
2017
Q4 | $206K | Sell |
4,882
-701
| -13% | -$27K | ﹤0.01% | 2307 |
|
|
2017
Q3 | $238K | Buy |
5,583
+767
| +16% | +$24.5K | ﹤0.01% | 2285 |
|
|
2017
Q2 | $63K | Buy |
4,816
+826
| +21% | +$10.9K | ﹤0.01% | 2836 |
|
|
2017
Q1 | $52K | Hold |
3,990
| – | – | ﹤0.01% | 2858 |
|
|
2016
Q4 | $51K | Buy |
3,990
+1,919
| +93% | +$29.6K | ﹤0.01% | 2888 |
|
|
2016
Q3 | $33K | Hold |
2,071
| – | – | ﹤0.01% | 2709 |
|
|
2016
Q2 | $26K | Buy |
+2,071
| New | +$25.9K | ﹤0.01% | 2798 |
|
Legal & General Group's MYOK Position: Q4 2020 in Review
Legal & General Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 30,432 shares — an estimated $4.15M sold.
Legal & General Group first reported a position in MYOK in Q2 2016 and held it in 18 quarters. The position peaked at $4.15M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.
- Legal & General Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
- Legal & General Group sold 30,432 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $4.15M.
- Legal & General Group first reported a position in MyoKardia, Inc. Common Stock in Q2 2016 and held it in 18 quarters.
- Legal & General Group's MyoKardia, Inc. Common Stock position peaked at $4.15M in Q3 2020.
- 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.
Based on Legal & General Group's 13F filing for Q4 2020, filed 12 Feb 2021.